Human-derived Collagen in ‘Trillion-won’ Scale

‘human-derived collagen in ‘trillion-won’ scale”

There will be a market for human-derived collagen in ‘trillion-won’ scale. “World’s first commercialization attempt”

Expectations in related fields are rising as the “human-derived collagen commercialization” project, which is expected to create about 1 trillion won in added value, began at the Daegu Gyeongbuk High-tech Medical Industry Promotion Foundation, a special smart wellness regulatory free zone.

Jung Min-ho, CEO of Endovision Co., Ltd., which participates in the human-derived collagen demonstration process along with Seoul National University Hospital in Bundang, said on the 27th, “Most of the human-derived collagen used at medical sites has been expensive and difficult to obtain.” Endo Vision, which is located in the Cheombok complex, is a company specializing in bio-materials such as haemostatic drugs and wound treatments. It is expanding its business area to human-derived collagen by developing wound treatments using heterogeneous collagen extracted from animals such as cows and pigs.

Chung majored in chemical engineering at a university, went to a graduate school of medicine and a pharmaceutical company, and started his own business in 2013. It is focusing on establishing its own production line that will utilize human-derived collagen by establishing a human organization bank within this year. Collagen is highly effective in treating tissues such as regeneration and has an infinite value of use in areas of tissue reconstruction such as joints and vertebrae. If collagen is injected into the surgical site, the wound can be recovered faster. In particular, human-derived collagen extracted from the human body has fewer side effects and shows faster resilience. The use of incineration waste, which amounts to 40 tons a year, is expected to generate 1 trillion won in added value.

However, CEO Chung predicts that the future licensing process will not be easy no matter how much the project takes place in the special regulatory free zone. Endo Vision developed a spinal endoscopy procedure with doctors in the early days of its founding, but it was not until June that it was approved.

The human-derived collagen commercialization project has not been tried anywhere in the world. It will be the only one in Daegu, South Korea. “There are many procedures to go through and regulations to be resolved,” he said. “In the field of bio-new materials development, more flexible thinking and administration are needed.”

※ Human body-derived collagen = Body fat discarded by liposuction. The business of recycling this to make new medical devices such as bio-inks and window dressing is a project to commercialize human-derived collagen. In July last year, the government took the first step toward commercialization when it designated four regions, including the Daegu Innovation Medical District, as a special regulatory free zone. Although human-derived collagen is classified as a high value-added medical material, all of it is incinerated in South Korea under the Waste Management Act.

출처: 매일신문 <a href=”″></a>